- ¥5bn
- ¥2bn
- ¥3bn
- 35
- 41
- 19
- 18
Annual balance sheet for Morpho, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3,392 | 3,060 | 2,712 | 2,936 | 2,525 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 419 | 485 | 517 | 658 | 591 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,077 | 3,593 | 3,330 | 3,690 | 3,250 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 126 | 25.5 | 52.5 | 49.2 | 66.3 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,550 | 3,860 | 3,707 | 4,263 | 4,146 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 362 | 453 | 509 | 609 | 468 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 400 | 461 | 559 | 622 | 526 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 4,150 | 3,399 | 3,149 | 3,641 | 3,620 |
| Total Liabilities & Shareholders' Equity | 4,550 | 3,860 | 3,707 | 4,263 | 4,146 |
| Total Common Shares Outstanding |